Search clinical trials for: Pyrotinib combined with capecitabine

Total 1260 results

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer

Breast Cancer

China
Fudan University

Active, not recruiting

Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Metastatic Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer (BLTN-Ic)

Metastatic Breast Cancer

China
Yongchang Zhang

Recruiting

PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC

HER2 Insertion Mutation Positive Advanced NSCLC

China
Jiangxi Provincial Cancer Hospital

Recruiting

A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

HER2-positive Metastatic Breast Cancer

China
Fudan University

Active, not recruiting

Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

Breast Cancer | HER2-positive Breast Cancer | Brain Metastases

China
Peking Union Medical College Hospital

Recruiting

Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer

HER2-positive Breast Cancer | Early-stage Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.

HER2-expressing Advanced Solid Tumors

China
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Study to Evaluate the Efficacy and Safety of CDK4/6 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer

Metastatic Breast Cancer
Fudan University

Recruiting

Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment

Breast Cancer

China
Fudan University
GeneQuantum Healthcare (Suzhou) Co., Ltd.

Recruiting

GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer

Advanced/ Metastatic Her-2 Positive Breast Cancer

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer

Breast Neoplasm Female
Qingdao Zhixin Health Technology Co., Ltd.
The Affiliated Hospital of Qingdao University

Unknown

A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer

HER-2 Positive Colorectal Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane

HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane

China
The Second Affiliated Hospital of Shandong First...

Recruiting

Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma

Gastric Cancer

China
Fudan University

Recruiting

Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer

Breast Cancer Stage I

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Safety and Efficacy of Oral Etoposide Combined With Antirotinib and Envollizumab in Elderly Patients With Lung Cancer

Progression Free Survival(PFS)
Peking University

Recruiting

Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

HER2-positive Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer

Breast Cancer

China
Hunan Cancer Hospital

Recruiting

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

Brain Metastases | Capecitabine | Metastatic HER2 Negative Breast Carcinoma | UDT1

China
Fujian Medical University Union Hospital

Not yet recruiting

Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer

Advanced Breast Cancer
XIANG YANQUN
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Zhujiang Hospital

Recruiting

Maintenance Therapy With Treprilimumab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Maintenance Therapy

China
Henan Cancer Hospital

Active, not recruiting

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

HER2 Positive Metastatic Breast Cancer

China
Zhao Chong
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Jiangxi... and other collaborators

Completed

Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial

Local Advanced High Risk Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients

Local Advanced High Risk Nasopharyngeal Carcinoma

China
Second Affiliated Hospital, School of Medicine,...
Zhejiang Cancer Hospital; First Affiliated Hospital of Zhejiang University; Sir... and other collaborators

Unknown

A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer

Colorectal Cancer

China
Fudan University

Recruiting

Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors

Effect of Drug | Gastrointestinal Tumor

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)

HER2 Positive Metastatic Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab

HER2 Positive Metastatic Breast Cancer

China
Zhejiang Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC

Metastatic Breast Cancer

China
Shandong Cancer Hospital and Institute

Not yet recruiting

Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer

Metastatic Breast Cancer
Zhejiang Cancer Hospital

Recruiting

Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC (HER2-VIP)

HER2-positive Advanced Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer

HER2 Positive Metastatic Breast Cancer

China
Xijing Hospital

Recruiting

Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma

Locally Advanced Gastric Adenocarcinoma

China
Xin-Hua Xu

Unknown

A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer

HER2 Positive Gastric Cancer

China
ART Fertility Clinics LLC

Completed

Effectiveness of PGT-A: IVF Versus ICSI

Genetic Condition

United Arab Emirates
University of Lisbon
Associacao Protectora dos Diabeticos de Portugal

Completed

Comparing Moderate and High-intensity Interval Training Protocols on Biomarkers in Type 2 Diabetes Patients (D2FIT)

Type 2 Diabetes
Changping Laboratory

Not yet recruiting

pBFS-guided cTBS Combined With iTBS Over the Superior Frontal Gyrus for Aphasia After Ischemic Stroke

Aphasia | Stroke, Ischemic
National Taiwan University Hospital

Completed

Synergistic Bilateral Upper-Limb Stroke Rehabilitation Based on Robotic Priming Technique

Stroke Rehabilitation

Taiwan
Fudan University

Recruiting

Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC

Biliary Tract Cancer

China
Universite du Quebec en Outaouais

Completed

A Virtual Arm to Stop Smoking

Cigarette Smoking

Canada
Tianjin Medical University Cancer Institute and...

Unknown

A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer

TTP

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Breast Cancer

China
University of Rzeszow

Recruiting

Effectiveness of Various Electrotherapy Methods in Treating People With Cervical Spine Pain Syndrome.

Cervical Spine Syndrome

Poland
Fujian Medical University Union Hospital

Recruiting

Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer

Breast Cancer | Adjuvant Therapy

China
Henan Cancer Hospital

Active, not recruiting

SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

RC-48 Combined With GLS-010 in HER2-overexpressed Patients With Previously Treated Unresectable Biliary Tract Cancer (RIGHT)

Biliary Carcinoma

China
Medical College of Wisconsin

Completed

A Study of HD-tDCS and Cognitive Training to Improve Cognitive Function in MCI

Mild Cognitive Impairment | Memory Disorders | Memory Loss

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Pyrotinib in Combination With Fulvestrant in Patients With HER2 Positive，HR-Positive Metastatic Breast Cancer

Metastatic Breast Cancer

China

3

Subscribe